Experienced in Hemolytic Transfusion Reaction

Dr. Bradley S. Taylor

Thoracic Surgery
University Of Maryland Surgical Associates PA
22 S Green St, 
Baltimore, MD 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Experienced in Hemolytic Transfusion Reaction
University Of Maryland Surgical Associates PA
22 S Green St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bradley Taylor is a Thoracic Surgeon in Baltimore, Maryland. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Hemolytic Transfusion Reaction. His top areas of expertise are Aortic Dissection, Thoracic Aortic Aneurysm, Cystic Medial Necrosis of Aorta, Heart Bypass Surgery, and Embolectomy. Dr. Taylor is currently accepting new patients.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hemolytic Transfusion Reaction.

Specialties
Thoracic Surgery
Licenses
Thoracic Surgery (Cardiothoracic Vascular Surgery) in PA
Hospital Affiliations
University Of Maryland Medical Center
Boca Raton Regional Hospital
Bethesda Hospital East
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

UNIVERSITY OF MARYLAND SURGICAL ASSOCIATES PA
22 S Green St, Baltimore, MD 21201
Other Locations
BOCACARE INC
801 Meadows Rd, Suite 102, Boca Raton, FL 33486
UNIVERSITY OF MARYLAND SURGICAL ASSOCIATES PA
300 Highland Ave, Hanover, PA 17331

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch
A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch
Enrollment Status: Recruiting
Publish Date: July 03, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Prospective, Multi-center Trial to Evaluate the Safety and Effectiveness of Beating Heart Mitral Valve Repair With the HARPOON™ System (RESTORE)
A Prospective, Multi-center Trial to Evaluate the Safety and Effectiveness of Beating Heart Mitral Valve Repair With the HARPOON™ System (RESTORE)
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
Enrollment Status: Active_not_recruiting
Publish Date: June 25, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Prospective, Multicenter, Non-Blinded, Non-Randomized Early Feasibility Study of the Relay Branch Thoracic Stent-Graft System in Subjects With Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery
A Prospective, Multicenter, Non-Blinded, Non-Randomized Early Feasibility Study of the Relay Branch Thoracic Stent-Graft System in Subjects With Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery
Enrollment Status: Active_not_recruiting
Publish Date: May 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients
Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients
Enrollment Status: Terminated
Publish Date: May 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Enrollment Status: Completed
Publish Date: April 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Procedure, Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

109 Total Publications

Concomitant valve-sparing pulmonic root replacement and valve-sparing aortic root replacement for giant cell arteritis.
Concomitant valve-sparing pulmonic root replacement and valve-sparing aortic root replacement for giant cell arteritis.
Journal: Multimedia manual of cardiothoracic surgery : MMCTS
Published: September 01, 2025
Similar Doctors
Experienced in Hemolytic Transfusion Reaction
Dr. Glenn J. Whitman
Thoracic Surgery | General Surgery
Experienced in Hemolytic Transfusion Reaction
Dr. Glenn J. Whitman
Thoracic Surgery | General Surgery

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (1.9 miles away)
410-955-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Glenn Whitman is a Thoracic Surgeon and a General Surgeon in Baltimore, Maryland. Dr. Whitman is rated as an Advanced provider by MediFind in the treatment of Hemolytic Transfusion Reaction. His top areas of expertise are Cardiogenic Shock, Restrictive Cardiomyopathy (RCM), Hemolysis, Heart Bypass Surgery, and Heart Transplant. Dr. Whitman is currently accepting new patients.

Experienced in Hemolytic Transfusion Reaction
Dr. Niv Ad
Thoracic Surgery | General Surgery
Experienced in Hemolytic Transfusion Reaction
Dr. Niv Ad
Thoracic Surgery | General Surgery
7901 Maple Ave, Suite A, 
Takoma Park, MD 
 (29.0 miles away)
202-524-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Niv Ad is a Thoracic Surgeon and a General Surgeon in Takoma Park, Maryland. Dr. Ad is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Transfusion Reaction. His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Hypertrophic Cardiomyopathy (HCM), Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG). Dr. Ad is currently accepting new patients.

Experienced in Hemolytic Transfusion Reaction
Dr. James S. Gammie
Thoracic Surgery | General Surgery
Experienced in Hemolytic Transfusion Reaction
Dr. James S. Gammie
Thoracic Surgery | General Surgery

Johns Hopkins University

600 N Wolfe St, Blalock 266, 
Baltimore, MD 
 (1.9 miles away)
410-502-4340
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Gammie is a Thoracic Surgeon and a General Surgeon in Baltimore, Maryland. Dr. Gammie is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Transfusion Reaction. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Valve Prolapse, Embolectomy, and Heart Bypass Surgery. Dr. Gammie is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Taylor's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile